Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Immune response to MenBVac in children vaccinated in Neufchâtel-en-Bray
2009-011401-16Phase 3Active
- Sponsor
- Rouen University Hospital
- Start
- Apr 2009
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of MenBvac in meningococcal disease, sponsored by Rouen University Hospital. Primary endpoints: Serum bactericidal activity titer against Neisseria meningitidis B:14,P1-7,16 and Percentage of children with bactericidal titer correlated with protection. Started Apr 2009; status: active.
02
Drugs
MenBvac
03
Conditions
meningococcal disease
Beyond the preview
Go deeper on 2009-011401-16.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-011401-16.